1-5 of 5
Kristen N. Ganjoo, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Outcomes, Secondary Malignancies, and Stem Cell Collection Following Bendamustine in Patients with Previously Treated Indolent Non-Hodgkin Lymphoma

Peter Martin, MD, Zhengming Chen, PhD, Bruce D. Cheson, MD, Tricia Ellis, Katherine Sue Robinson, MD FRCPC, Michael E. Williams, MD, Saurabh A. Rajguru, MD, Jonathan W. Friedberg, MD MMSc, Richard H. van der Jagt, Ann S. LaCasce, MD, Robin Joyce, MD, Kristen N. Ganjoo, MD, Nancy L Bartlett, MD, Bernard Lemieux, MD FRCP, Ari M. Vander Walde, MD, M.P.H., Jordan A. Herst, MD FRCPC, Jeffrey Szer, MB BS FRACP, Michael H. Bar, MD, Fernando Cabanillas, MD, Anthony J. Dodds, FRACP, FRCPA, Paul G. Montgomery, MD, Bryn Pressnail, Mitchell R. Smith, MD PhD, John P. Leonard, MD
Journal: Blood
Blood (2015) 126 (23): 3961.
https://doi.org/10.1182/blood.V126.23.3961.3961
Published: 2015
Journal Articles

Anti-Tumor Activity of Low Dose Ocaratuzumab in Previously Treated Follicular Lymphoma Patients with Low-Affinity CD16 Polymorphisms

Phuong H Le, MS, Andres Forero-Torres, MD, Nam H. Dang, MD, PhD, Mitchell R Smith, MD, PhD, Brian K Link, MD, Kristen N. Ganjoo, MD, Kensei Tobinai, MD, PhD, Minna Du, Adrienne O'Reilly, MS, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2012) 120 (21): 4884.
https://doi.org/10.1182/blood.V120.21.4884.4884
Published: 2012
Journal Articles

Sustained Depletion of B-Cells by a Humanized, Fc-Engineered Anti-CD20 Antibody, AME-133v, in Patients with Relapsed Follicular Lymphoma

Jennifer Wayne, MS, Kristen N. Ganjoo, MD, Andres Forero, MD, Brad Pohlman, MD, Sven de Vos, MD, PhD, Susan P. Carpenter, PhD, James E Wooldridge, MD, Shashidhara Marulappa, DVM, MVSc, MBA, Vinay Jain, MBBS, MD, FACP
Journal: Blood
Blood (2011) 118 (21): 4977.
https://doi.org/10.1182/blood.V118.21.4977.4977
Published: 2011
Journal Articles

Cardiac Toxicity Associated with the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin) in Combination with CHOP (A-CHOP) Chemotherapy for Peripheral T Cell Lymphoma (PTCL): The ECOG 2404 Trial.

Ranjana H Advani, MD, Fangxin Hong, Ph.D., Kristen N. Ganjoo, MD, Judith B. Manola, MS, Lode J. Swinnen, MBChB, Thomas M Habermann, MD, Sandra J Horning, MD
Journal: Blood
Blood (2009) 114 (22): 1671.
https://doi.org/10.1182/blood.V114.22.1671.1671
Published: 2009
Journal Articles

Rituximab, Bevacizumab (Avastin) and CHOP (RA-CHOP) for Patients with Diffuse Large B-Cell Lymphoma (DLBCL).

Kristen N. Ganjoo, MD, Leo Gordon, MD, Michael J. Robertson, MD, Sandra J. Horning, MD
Journal: Blood
Blood (2004) 104 (11): 1384.
https://doi.org/10.1182/blood.V104.11.1384.1384
Published: 2004